Antti Muuronen

1.1k total citations
30 papers, 830 citations indexed

About

Antti Muuronen is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Neurology. According to data from OpenAlex, Antti Muuronen has authored 30 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 8 papers in Epidemiology and 7 papers in Neurology. Recurrent topics in Antti Muuronen's work include Cerebrovascular and Carotid Artery Diseases (6 papers), Acute Ischemic Stroke Management (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Antti Muuronen is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (6 papers), Acute Ischemic Stroke Management (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Antti Muuronen collaborates with scholars based in Finland, Sweden and Canada. Antti Muuronen's co-authors include Markku Kaste, Kari Murros, Matti Hillbom, Tomas Hindmarsh, E Nikkilä, Marja Hedman, Mikko Taina, Ritva Vanninen, Hans Bergman and T Telakivi and has published in prestigious journals such as PLoS ONE, Stroke and Journal of Hepatology.

In The Last Decade

Antti Muuronen

29 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antti Muuronen Finland 16 230 209 197 141 102 30 830
M Haguenau France 12 354 1.5× 329 1.6× 344 1.7× 284 2.0× 44 0.4× 51 1.0k
Jin‐Man Jung South Korea 19 399 1.7× 239 1.1× 312 1.6× 282 2.0× 85 0.8× 79 909
Vanja Bašić Kes Croatia 16 174 0.8× 175 0.8× 87 0.4× 107 0.8× 36 0.4× 68 766
Radosław Kaźmierski Poland 14 267 1.2× 141 0.7× 90 0.5× 159 1.1× 60 0.6× 60 736
Shoji Arihiro Japan 13 279 1.2× 301 1.4× 72 0.4× 77 0.5× 77 0.8× 28 596
Afshin Parsa United States 20 121 0.5× 264 1.3× 308 1.6× 104 0.7× 122 1.2× 34 1.3k
Kamil Zeleňák Slovakia 15 328 1.4× 212 1.0× 60 0.3× 261 1.9× 66 0.6× 79 692
Qian Jia China 22 596 2.6× 146 0.7× 408 2.1× 259 1.8× 59 0.6× 61 1.4k
Attila Valikovics Hungary 14 125 0.5× 106 0.5× 235 1.2× 189 1.3× 42 0.4× 29 563
Yimei Wang China 17 97 0.4× 172 0.8× 136 0.7× 99 0.7× 33 0.3× 50 853

Countries citing papers authored by Antti Muuronen

Since Specialization
Citations

This map shows the geographic impact of Antti Muuronen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antti Muuronen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antti Muuronen more than expected).

Fields of papers citing papers by Antti Muuronen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antti Muuronen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antti Muuronen. The network helps show where Antti Muuronen may publish in the future.

Co-authorship network of co-authors of Antti Muuronen

This figure shows the co-authorship network connecting the top 25 collaborators of Antti Muuronen. A scholar is included among the top collaborators of Antti Muuronen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antti Muuronen. Antti Muuronen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taina, Mikko, Pirjo Mustonen, Marja Hedman, et al.. (2017). Soluble Urokinase-type Plasminogen Activator Receptor Predicts All-cause 5-Year Mortality in Ischemic Stroke and TIA. In Vivo. 31(3). 381–386. 10 indexed citations
2.
3.
Muuronen, Antti, Mikko Taina, Kari Pulkki, et al.. (2017). vWF correlates with visceral and pericardial adipose tissue in patients with a recent stroke of suspected cardiogenic etiology. PLoS ONE. 12(6). e0178508–e0178508. 3 indexed citations
4.
Taina, Mikko, Ritva Vanninen, Petri Sipola, et al.. (2016). Cardiac CT Differentiates Left Atrial Appendage Thrombi from Circulatory Stasis in Acute Stroke Patients.. PubMed. 30(5). 671–6. 8 indexed citations
5.
Arponen, Otso, Antti Muuronen, Mikko Taina, et al.. (2015). Acute Phase IL-10 Plasma Concentration Associates with the High Risk Sources of Cardiogenic Stroke. PLoS ONE. 10(4). e0120910–e0120910. 9 indexed citations
6.
Muuronen, Antti, Mikko Taina, Marja Hedman, et al.. (2015). Increased Visceral Adipose Tissue as a Potential Risk Factor in Patients with Embolic Stroke of Undetermined Source (ESUS). PLoS ONE. 10(3). e0120598–e0120598. 14 indexed citations
7.
Muuronen, Antti, Otso Arponen, Pirjo Mustonen, et al.. (2015). Left Atrial Appendage Morphology in Patients with Suspected Cardiogenic Stroke without Known Atrial Fibrillation. PLoS ONE. 10(3). e0118822–e0118822. 46 indexed citations
8.
Taina, Mikko, Antti Muuronen, Otso Arponen, et al.. (2014). Morphological and Volumetric Analysis of Left Atrial Appendage and Left Atrium: Cardiac Computed Tomography-Based Reproducibility Assessment. PLoS ONE. 9(7). e101580–e101580. 18 indexed citations
9.
Taina, Mikko, Petri Sipola, Antti Muuronen, et al.. (2014). Determinants of Left Atrial Appendage Volume in Stroke Patients without Chronic Atrial Fibrillation. PLoS ONE. 9(3). e90903–e90903. 6 indexed citations
10.
Simula, Sakari, Antti Muuronen, Mikko Taina, et al.. (2013). Effect of Middle Cerebral Artery Territory Ischemic Stroke on QT Interval. Journal of Stroke and Cerebrovascular Diseases. 23(4). 717–723. 21 indexed citations
11.
Palomäki, Heikki, Antti Muuronen, Raili Raininko, Anneli Piilonen, & Markku Kaste. (2003). Administration of Nonionic Iodinated Contrast Medium Does Not Influence the Outcome of Patients with Ischemic Brain Infarction. Cerebrovascular Diseases. 15(1-2). 45–50. 12 indexed citations
12.
Muuronen, Antti, et al.. (1998). Prolonged impairment in activities of daily living due to postdural puncture headache after diagnostic lumbar puncture. Anaesthesia. 53(3). 299–302. 25 indexed citations
13.
Vataja, Risto, Antti Muuronen, Matti Hillbom, et al.. (1994). Neurological recovery after liver transplantation: a prospective study of 22 patients. Transplant International. 7(s1). 50–51. 2 indexed citations
14.
Höckerstedt, K., et al.. (1992). Encephalopathy and neuropathy in end-stage liver disease before and after liver transplantation. Journal of Hepatology. 16(1-2). 31–37. 58 indexed citations
15.
Muuronen, Antti. (1992). Natural history of carotid artery disease.. PubMed. 81(2). 89–92. 3 indexed citations
16.
Numminen, Heikki, Matti Hillbom, Heikki Vapaatalo, et al.. (1991). Effects of exercise and ethanol ingestion on platelet thromboxane release in healthy men. Metabolism. 40(7). 695–701. 4 indexed citations
17.
Muuronen, Antti, Hans Bergman, Tomas Hindmarsh, & T Telakivi. (1989). Influence of Improved Drinking Habits on Brain Atrophy and Cognitive Performance in Alcoholic Patients: A 5‐Year Follow‐up Study. Alcoholism Clinical and Experimental Research. 13(1). 137–141. 69 indexed citations
18.
Hillbom, Matti, Antti Muuronen, & Jack Neiman. (1987). Liver disease and platelet function in alcoholics.. BMJ. 295(6598). 581–581. 12 indexed citations
19.
Muuronen, Antti, Markku Kaste, E Nikkilä, & E.‐M. Tolppanen. (1985). Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.. BMJ. 291(6507). 1481–1483. 63 indexed citations
20.
Kaste, Markku, Antti Muuronen, E Nikkilä, & Pertti J. Neuvonen. (1983). Increase of low serum concentrations of high-density lipoprotein (HDL) cholesterol in TIA-patients treated with phenytoin.. Stroke. 14(4). 525–530. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Haguenau Breakdown of academic impact, for papers by Jin‐Man Jung Breakdown of academic impact, for papers by Vanja Bašić Kes Breakdown of academic impact, for papers by Radosław Kaźmierski Breakdown of academic impact, for papers by Shoji Arihiro Breakdown of academic impact, for papers by Afshin Parsa Breakdown of academic impact, for papers by Kamil Zeleňák Breakdown of academic impact, for papers by Qian Jia Breakdown of academic impact, for papers by Attila Valikovics Breakdown of academic impact, for papers by Yimei Wang
Rankless by CCL
2026